117 related articles for article (PubMed ID: 7306924)
21. Prolactin levels in populations at risk for breast cancer.
Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
[TBL] [Abstract][Full Text] [Related]
22. [Prolactin and human cancer of the breast. I. Levels of correlation].
Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
[TBL] [Abstract][Full Text] [Related]
23. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
24. 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment.
Kalleinen N; Polo-Kantola P; Irjala K; Porkka-Heiskanen T; Vahlberg T; Virkki A; Polo O
J Clin Endocrinol Metab; 2008 May; 93(5):1655-61. PubMed ID: 18319308
[TBL] [Abstract][Full Text] [Related]
25. [Prolactin and steroid hormones in the blood in local disorders of the lymph-plasma circulation in breast cancer patients].
Berzin SA; Tokar' VN
Sov Med; 1988; (12):16-9. PubMed ID: 3242113
[No Abstract] [Full Text] [Related]
26. Serum levels of cortisol, dehydroepiandrosterone, dehydroepiandrosterone sulphate, estrone and prolactin after surgical trauma in postmenopausal women.
Adami HO; Axelsson O; Carlström K; Vegelius J; Akerström G
Ups J Med Sci; 1982; 87(3):201-13. PubMed ID: 6218673
[TBL] [Abstract][Full Text] [Related]
27. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
[TBL] [Abstract][Full Text] [Related]
28. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
Bird CE; Cook S; Owen S; Sterns EE; Clark AF
Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
[TBL] [Abstract][Full Text] [Related]
29. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Michaud DS; Manson JE; Colditz GA; Longcope C; Rosner B; Speizer FE
J Natl Cancer Inst; 1999 Apr; 91(7):629-34. PubMed ID: 10203283
[TBL] [Abstract][Full Text] [Related]
30. Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
Maddox PR; Jones DL; Mansel RE
Br J Cancer; 1992 Mar; 65(3):456-60. PubMed ID: 1558804
[TBL] [Abstract][Full Text] [Related]
31. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
[TBL] [Abstract][Full Text] [Related]
32. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
33. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
34. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
[TBL] [Abstract][Full Text] [Related]
35. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
36. Mastectomy stimulates prolactin release in breast cancer patients.
Holtkamp W; Osterloh B; Rauschecker H; Nagel GA
Anticancer Res; 1986; 6(4):725-7. PubMed ID: 3752952
[TBL] [Abstract][Full Text] [Related]
37. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth.
Kwa HG; Cleton F; Bulbrook RD; Wang DY; Hayward JL
Int J Cancer; 1981 Jul; 28(1):31-4. PubMed ID: 7309279
[TBL] [Abstract][Full Text] [Related]
38. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
[TBL] [Abstract][Full Text] [Related]
39. Menopausal status does not predict Oncotype DX recurrence score.
Carr DN; Vera N; Sun W; Lee MC; Hoover S; Fulp W; Acs G; Laronga C
J Surg Res; 2015 Sep; 198(1):27-33. PubMed ID: 26095420
[TBL] [Abstract][Full Text] [Related]
40. [Correlations between prolactin and somatotropic hormone in human breast cancer].
Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]